Best Practices and Gaps in Current Regulatory and Health Technology Assessment Real‐World Evidence Policies for Medicines and Medical Devices: Current State of Play and Next Steps
Clinical and Translational Science · 2026-03 · 19 (3)
DOI: 10.1111/cts.70507 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Science, online erschienen am 23.02.2026. Verfasst von Katharine Cresswell und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Health and Care Excellence, London, England, UK. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Equipment and Supplies, Health Policy, Practice Guidelines as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovative Health Initiative, National Institute for Health and Care Excellence.
Abstract (Originalsprache)
Real‐world data (RWD) offers a valuable opportunity to access vast information that can drive research and generate real‐world evidence (RWE), offering insights into the actual delivery of care and patient outcomes beyond the limitations of traditional clinical trials. However, policy development has struggled to keep pace as decision‐makers balance the potential benefits of RWE with lingering technical concerns about its limitations. To identify emerging best practices and policy gaps, the Integration of Heterogeneous Data and Evidence towards Regulatory and HTA Acceptance (IDERHA) team conducted a landscape review of current policy documents on the use of RWD and RWE in regulatory and Health Technology Assessment (HTA) decision‐making for medicines and medical devices. The review report was released for public consultation in 2024. Our analysis highlights a growing body of knowledge on RWE, with increasing momentum towards developing standardized best practices. Despite notable progress in policy development over the past 5 years, broader acceptance and use of RWE in regulatory and HTA decision‐making remain uneven and inconsistent. In the year since the original analysis was completed, there have been more policies released and finalized. Other researchers have conducted additional policy reviews and had similar findings as the IDHERA team. This underscores the importance of aligning expectations in the emerging field of RWE on appropriate research standardization, RWD utilization and laying the groundwork for further policy development. These efforts will contribute significantly to the dialogue on optimizing health data to improve patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute for Health and Care Excellence, London, England, UK.
- Sanford School of Public Policy, Duke University, Durham, NC, USA.
- Johnson & Johnson, New Brunswick, NJ, USA.
- Takeda, Tokyo, Japan.
- Sanofi, Paris, Île-de-France, France.
- University of Copenhagen, Paris, Île-de-France, France.
Förderung
- Innovative Health Initiative
- National Institute for Health and Care Excellence
Zitieren
APA
Cresswell, K., Claire, R., Issa, L., Kubehl, L., Bilal, O., Purcell, R., Clemente, A., Wested, J., Jensen, L. G., Sasane, M., Peeters, R., Shinkins, B., & Colvin, H. (2026). Best Practices and Gaps in Current Regulatory and Health Technology Assessment Real‐World Evidence Policies for Medicines and Medical Devices: Current State of Play and Next Steps. Clinical and Translational Science, 19(3). https://doi.org/10.1111/cts.70507
Vancouver
Cresswell K, Claire R, Issa L, Kubehl L, Bilal O, Purcell R, et al. Best Practices and Gaps in Current Regulatory and Health Technology Assessment Real‐World Evidence Policies for Medicines and Medical Devices: Current State of Play and Next Steps. Clinical and Translational Science. 2026;19(3). doi:10.1111/cts.70507
BibTeX
@article{Cresswell2026,
author = {Cresswell, Katharine and Claire, Ravinder and Issa, Laila and Kubehl, Luke and Bilal, Omnia and Purcell, Rose and Clemente, Amaya and Wested, Jakob and Jensen, Lotte Groth and Sasane, Medha and Peeters, Rita and Shinkins, Bethany and Colvin, Heather},
title = {Best Practices and Gaps in Current Regulatory and Health Technology Assessment Real‐World Evidence Policies for Medicines and Medical Devices: Current State of Play and Next Steps},
journal = {Clinical and Translational Science},
year = {2026},
volume = {19},
number = {3},
doi = {10.1111/cts.70507}
}
EUVIMED